Alpha 2.0
Login Register
» Articles » PMID: 6986981

Comparison of the Immunosuppressive Effects of Asparaginases from Escherichia Coli and Vibrio Succinogenes

Overview
Journal Cancer Res
Specialty Oncology
Date 1980 Apr 1
PMID 6986981
Citations 10
Authors
D L Durden
J A Distasio
Affiliations
Soon will be listed here.
Citing Articles

Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia.

Zhou R, Liang T, Li T, Huang J, Chen C Front Oncol. 2023; 13:1070069.

PMID: 36816964 PMC: 9929349. DOI: 10.3389/fonc.2023.1070069.

Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.

Van Trimpont M, Peeters E, De Visser Y, Schalk A, Mondelaers V, De Moerloose B Cancers (Basel). 2022; 14(4).

PMID: 35205650 PMC: 8870365. DOI: 10.3390/cancers14040902.

The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.

Nguyen H, Durden D, Lavie A Sci Rep. 2017; 7:41643.

PMID: 28139703 PMC: 5282591. DOI: 10.1038/srep41643.

The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.

Sannikova E, Bulushova N, Cheperegin S, Gubaydullin I, Chestukhina G, Ryabichenko V Mol Biotechnol. 2016; 58(8-9):528-39.

PMID: 27198565 DOI: 10.1007/s12033-016-9950-1.

Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Chien W, Allas S, Rachinel N, Sahakian P, Julien M, Le Beux C Invest New Drugs. 2014; 32(5):795-805.

PMID: 24829072 DOI: 10.1007/s10637-014-0102-9.